Preoperative GLP-1 Receptor Agonist Use and Risk of Postoperative Respiratory Complications

JAMA. 2024 May 21;331(19):1672-1673. doi: 10.1001/jama.2024.5003.
No abstract available

Plain language summary

This cohort study evaluates the risk of postoperative respiratory complications among patients with diabetes undergoing surgery who had vs those who had not a prescription fill for glucagon-like peptide 1 receptor agonists.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Glucagon-Like Peptide-1 Receptor Agonists* / administration & dosage
  • Glucagon-Like Peptide-1 Receptor Agonists* / adverse effects
  • Glucagon-Like Peptide-1 Receptor Agonists* / therapeutic use
  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Humans
  • Hypoglycemic Agents* / adverse effects
  • Hypoglycemic Agents* / therapeutic use
  • Male
  • Middle Aged
  • Postoperative Complications / chemically induced
  • Respiratory Tract Diseases* / chemically induced
  • Respiratory Tract Diseases* / etiology
  • Risk
  • Withholding Treatment

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Glucagon-Like Peptide-1 Receptor Agonists